Ledger.Open graph →
SEC Form D · filed March 31, 2015

CATABASIS PHARMACEUTICALS INC

Offering
$20.4M
Sold
$12.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Ron C. Laufer · Cambridge, MADirectorNicholas C. Galakatos · Cambridge, MADirectorKenneth C. Bate · Cambridge, MADirectorJill C. Milne · Cambridge, MAExec · DirectorMichael C. Ross · Cambridge, MADirectorJeff Alexander · Colorado Springs, CODirectorRick P. Smith · Venice, CAExec · DirectorMike Schneider · Durham, NCDirectorJean C. George · Cambridge, MADirectorIan C. Sanderson · Cambridge, MAExecDavid Juliano · Sunnyvale, CADirectorRon Bernal · Sunnyvale, CADirectorS Squared Capital, LLC · New York, NYExec · DirectorS Squared Technology, LLC · New York, NYDirectorKenneth C. Bate · Cambridge, MADirectorJean C. George · Cambridge, MADirectorIan C. Sanderson · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗